Avid Radiopharmaceuticals
http://dbpedia.org/resource/Avid_Radiopharmaceuticals an entity of type: Thing
Avid Radiopharmaceuticals is an American company, founded by Dr. Daniel Skovronsky, and based at the University City Science Center research campus in Philadelphia, Pennsylvania. The company has developed a radioactive tracer called florbetapir (18F). Florbetapir can be used to detect beta amyloid plaques in patients with memory problems using positron emission tomography (PET) scans, making the company the first to bring to market an FDA-approved method that can directly detect this hallmark pathology of Alzheimer's disease.
rdf:langString
rdf:langString
Avid Radiopharmaceuticals
rdf:langString
Avid Radiopharmaceuticals
rdf:langString
Avid Radiopharmaceuticals
xsd:integer
27824553
xsd:integer
1084078565
rdf:langString
Dr. Daniel Skovronsky
rdf:langString
United States
rdf:langString
Private
rdf:langString
Avid Radiopharmaceuticals is an American company, founded by Dr. Daniel Skovronsky, and based at the University City Science Center research campus in Philadelphia, Pennsylvania. The company has developed a radioactive tracer called florbetapir (18F). Florbetapir can be used to detect beta amyloid plaques in patients with memory problems using positron emission tomography (PET) scans, making the company the first to bring to market an FDA-approved method that can directly detect this hallmark pathology of Alzheimer's disease. Eli Lilly and Company announced on November 8, 2010, that they would acquire Avid for $800 million, with $300 million paid out up front and the balance paid later on.
xsd:nonNegativeInteger
10720
